ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,459.10
      1.11%
      US Tech 100
      18,514.00
      1.00%
      Dow Jones
      40,589.34
      1.64%
      Brent Oil
      79.745
      0.00%
      Bitcoin
      67,802.21
      -0.16%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Tonix Pharmaceuticals Holding Corporation (TNXP)

      7. Tonix Pharmaceuticals Holding Corporation (TNXP) Financials

      Tonix Pharmaceuticals Holding Corporation

      Tonix Pharmaceuticals Holding Corporation (TNXP)

      NASDAQ
      0.55
      -0.0295
      (-5.09%)
      Closed July 27 4:00PM
      Delayed by 15 minutes
      0.56
      0.01
      (1.82%)
      After Hours: 7:59PM
      Delayed by 15 minutes

      Tonix Pharmaceuticals Holding Corporation Financial Summary

      The current TNXP market cap is 1.67M. The company's latest EPS is USD -39.0717 and P/E is -0.01.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 003.99M3.78M2.48M
      Operating Income -33.9M-29M-28.15M-27.33M-21.35M
      Net Income -33.01M-28.36M-27.98M-27.32M-14.94M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 00007.77M
      Operating Income -28.83M-50.51M-92.31M-112.09M-118.38M
      Net Income -31.09M-52.17M-92.29M-116.88M-116.66M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 179.09M159.74M139.28M154.46M135.34M
      Total Liabilities 13.66M19.27M18.45M48.93M27.2M
      Total Equity 165.43M140.46M120.83M105.53M108.14M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 14.56M98.18M240.9M225.69M154.46M
      Total Liabilities 5.14M10.54M22.18M18.51M48.93M
      Total Equity 9.42M87.65M218.72M207.18M105.53M

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -32.91M-56.28M-79.66M-102M-17.58M
      Investing -3.8M-27.82M-28.64M-29.07M-108k
      Financing -11.5M-10.47M-4.2M36.52M-212k
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -26.68M-48.57M-75.56M-98.05M-102M
      Investing -17k-8.56M-35.31M-48.15M-29.07M
      Financing 12.92M123.11M212.49M87.84M36.52M

      Stats and Ratios

      Market Cap 1.67M
      Price to Earnings Ratio -0.01
      Price to Sales Ratio 0.21
      Price to Cash Ratio 0.07
      Price to Book Ratio 0.02
      Dividend Yield -

      Share Statistics

      Shares Outstanding 2.99M
      Average Volume (1 week) 5.48M
      Average Volume (1 Month) 3.78M
      52 Week Change -98.96%
      52 Week High 58.24
      52 Week Low 0.462
      Spread (Intraday) 0.01 (2.66%)

      Company Info

      Company Name Tonix Pharmaceuticals Holding Corporation
      Address 769 basque way
      carson city, nevada 89706
      Website https://www.tonixpharma.com
      Industry pharmaceutical preparations (2834)